Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension

ClinicalTrials.gov ID: NCT00635232

Public ClinicalTrials.gov record NCT00635232. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 3:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo And Active-Controlled, Parallel Group Study To Evaluate The Dose-Related Efficacy And Safety Of PS433540 In Subjects With Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn which doses of PS433540 should be given to patients with high blood pressure to lower their blood pressure. This study will also examine how safe PS433540 is when taken by patients with high blood pressure. Approximately 720 patients will be evaluated so that about 375 patients will be entered into the treatment phase of the study and be given PS433540.

Study identification

NCT ID
NCT00635232
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ligand Pharmaceuticals
Industry
Enrollment
261 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
Nov 2008 (Actual)
Completion
Dec 2008 (Actual)
Last update posted
Sep 16, 2011

2008

United States locations

U.S. sites
40
U.S. states
17
U.S. cities
39
Facility City State ZIP Site status
Advanced Clinical Research 1000 Forrest Place Suite 2 Pell City Pell City Alabama 35128 —
Premiere Pharmaceutical Research, LLC Tempe Arizona 85282 —
Genova Clinical Research AZ Tucson Arizona 85741 —
Advanced Clinical Research Institute Anaheim California 92801 —
Associated Pharmaceutical Research Center Buena Park California 90620 —
Clinical Trials Research CA Lincoln California 95648 —
Long Beach Center for Clinical Research Long Beach California 90806 —
National Research Institute Los Angeles California 90057 —
Superior Regional Research, LLC Sacramento California 95825 —
Orange County Research Center Tustin California 92780 —
Westlake Medical Center Westlake Village California 91361 —
Univ. Clinical Research Deland, LLC. DeLand Florida 32720 —
Allan Graff Fort Lauderdale Florida 33308 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
North County Medical Sebastian Florida 32958 —
Q Clinical Research Decatur Georgia 30035 —
Clinical Research Atlanta Stockbridge Georgia 30281 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Cedar Crosse Research Center Chicago Illinois 60607 —
Midwest Institute for Clinical Research Indianapolis Indiana 46260 —
MD Medical Research Oxon Hill Maryland 20745 —
Cary Medical Research Cary North Carolina 27518 —
Metrolina Medical Research Charlotte North Carolina 28209 —
Unifour Medical Research NC Hickory North Carolina 28601 —
Northstate Clinical Research Lenoir North Carolina 28645 —
Triangle Medical Research NC Raleigh North Carolina 27609 —
Crescent Medical Research Salisbury North Carolina 28144 —
New Hanover Medical Rersearch Wilmington North Carolina 28401 —
Peidmont Medical Research Associates Winston-Salem North Carolina 27103 —
The Lindner Center Cincinnati Ohio 45219 —
Delaware Smith Clinic Delaware Ohio 43015 —
Smith Clinic Marion Ohio 43302 —
COR Clinical Research, L.L.C Oklahoma City Oklahoma 73103 —
Brandywine Clinical Research Center Downingtown Pennsylvania 19335 —
Hypertension & Nephrology Inc Providence Rhode Island 02904 —
Punzi Medical Center Carrollton Texas 75006 —
Innovative Clinical Trials San Antonio Texas 78229 —
IMED Research PA San Antonio Texas 78258 —
Hampton Roads Center for Clinical Research Norfolk Virginia 23502 —
Gemini Scientific LLC Madison Wisconsin 53719 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00635232, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2011 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00635232 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →